Gene therapy for critical limb ischaemia: The TAMARIS trial

The Lancet

Volumn 377, Issue 9781, 2011, Pages 1894-1896

  Fowkes, F Gerry R ^a   Price, Jackie F ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT; FIBROBLAST GROWTH FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NAFTIDROFURYL; PENTOXIFYLLINE; PLACEBO; PROSTANOID; RECOMBINANT PROTEIN; VASOACTIVE AGENT;

ANGIOGENESIS; ANTICOAGULANT THERAPY; ATHEROSCLEROSIS; CELL MIGRATION; CELL PROLIFERATION; CLINICAL TRIAL (TOPIC); CRITICAL LIMB ISCHEMIA; DISEASE SEVERITY; DRUG EFFICACY; DRUG INHIBITION; DRUG SAFETY; GANGRENE; GENE OVEREXPRESSION; GENE THERAPY; GENE TRANSFER; HUMAN; INCIDENCE; LEG AMPUTATION; LEG PAIN; LEG REVASCULARIZATION; LEG ULCER; LIMB ISCHEMIA; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NOTE; PRIORITY JOURNAL; RISK FACTOR; STEM CELL TRANSPLANTATION; SURGICAL TECHNIQUE; SYMPTOM; TREATMENT RESPONSE; ULCER HEALING;

EID: 79958139455     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)60441-8     Document Type: Note

References (11)

1. V Aboyans, MH Criqui The epidemiology of peripheral arterial disease RS Dieter RA Dieter III Peripheral arterial disease 2009 McGraw Hill New York 1 25
2. L Norgren, WR Hiatt, JA Dormandy, MR Nehler, KA Harris, FGR Fowkes on behalf of the TASC II Working Group Inter-society consensus for the management of peripheral arterial disease J Vasc Surg 45 suppl S 2007 S5 S67
3. AJ Ruffolo, M Romano, A Ciapponi Prostanoids for critical limb ischaemia Cochrane Database Syst Rev 1 2010 CD006544.
4. JM Isner, A Pieczek, R Schainfeld Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb Lancet 348 1996 370 374 (Pubitemid 26261511)
5. H Lawall, P Bramlage, B Amann Stem cell and progenitor cell therapy in peripheral artery disease: a critical appraisal Thromb Haemost 103 2010 696 709
6. DJ Collinson, R Donnelly Therapeutic angiogenesis in peripheral arterial disease: can biotechnology produce an effective collateral circulation? Eur J Vasc Endovasc Surg 28 2004 9 23 (Pubitemid 38950133)
7. R Gupta, J Tongers, DW Losordo Human studies of angiogenic gene therapy Circ Res 105 2009 724 736
8. J De Haro, F Acin, A Lopez-Quintana, A Florez, E Martinez-Aguilar, C Varela Meta-analysis of randomized, controlled clinical trials in angiogenesis: gene and cell therapy in peripheral arterial disease Heart Vessels 24 2009 321 328
9. C Kalka, I Baumgartner Gene and stem cell therapy in peripheral arterial occlusive disease Vasc Med 13 2008 157 172 (Pubitemid 351954349)
10. J Belch, WR Hiatt, I Baumgartner on behalf of the TAMARIS Committees and Investigators Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia Lancet 2011 10.1016/S0140-6736(11)60394-2 published online May 31.
11. S Nikol, I Baumgartner, E Van Belle Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischaemia Mol Ther 16 2008 972 978 (Pubitemid 351587109)